YY1 and metabolic dysfunction-associated steatotic liver disease: By utilizing both animal models and cell line models, YY1 was found to regulate hepatic lipid metabolism either directly activating the DNL pathway or inhibiting the FAO pathway that further induced NAFLD initiation and progression (Lu et al, 2014; Yuan et al, 2018; Li et al, 2019).